Home › Endometrial Cancer › California › Mountain View
Endometrial Cancer clinical trials in Mountain View, CA
12 studies for Endometrial Cancer are looking for participants at sites in and around Mountain View (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi away
- VA Palo Alto Health Care System, Palo Alto · 5 mi away
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecruitingPhase 3
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi away
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- Stanford Cancer Institute, Stanford · 5 mi away
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RecruitingPhase 1
- Stanford University Medical Center, Stanford · 5 mi away
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
RecruitingPhase 1
- Stanford, Palo Alto · 5 mi away
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
RecruitingPhase 2
- Stanford Cancer Center, Palo Alto · 5 mi away
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Stanford Cancer Institute, Stanford University, Palo Alto · 5 mi away
A Study of PHST001 in Advanced Solid Tumors
RecruitingPhase 1
- Stanford University School of Medicine, Palo Alto · 5 mi away
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RecruitingPhase 2
- 150, Palo Alto · 5 mi away
A Study of LY4175408 in Participants With Advanced Cancer
RecruitingPhase 1
- Stanford Medicine Cancer Center, Stanford · 5 mi away
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
RecruitingPhase 1/2
- Stanford Women's Cancer Center, Palo Alto · 5 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Stanford · 5 mi away
Endometrial Cancer trials in other cities
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Chicago, IL25 studies
- Columbus, OH25 studies
- Queens, NY25 studies
Other studies in Mountain View
- Cancer (all types)40 studies
- Breast Cancer25 studies
- Metastatic Cancer25 studies
- Non-Small Cell Lung Cancer21 studies
- Acute Myeloid Leukemia19 studies
- Ovarian Cancer19 studies
- Autism Spectrum Disorder17 studies
- Lung Cancer17 studies
- Heart Failure15 studies
- Prostate Cancer15 studies
- Autism13 studies
- Acute Lymphoblastic Leukemia13 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.